Airwaves

Wisia Wedzicha, Editor in Chief

The first 150 words of the full text of this article appear below.

Traffic accidents are a major issue in patients with sleep apnoea and nasal CPAP (continuous positive airway pressure) therapy improves driving performance. However, information is required on the time course of improvement so that patients can be advised when to restart driving after starting CPAP or whether they can drive safely after missing treatment. Turkington and colleagues used a simulator to study the time course of driving performance after starting CPAP therapy. They found that driving performance had significantly improved by 7 days and that, after stopping CPAP therapy, the improvements were maintained for up to 1 week after withdrawal although the effect size was now smaller. This study provides some valuable information on driving performance for all of us who treat patients with sleep apnoea.
See page 56

Time plot of median tracking error in CPAP treated patients and controls: *significant difference between the two groups at day 7 . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Clinical dose-response relationship of fluticasone propionate in adults with asthma

M Masoli, M Weatherall, S Holt, and R Beasley
Thorax 2004 59: 16-20. [Abstract] [Full Text] [PDF]

The developing story of antioxidants and asthma

R Hubbard and A Fogarty
Thorax 2004 59: 3-4. [Extract] [Full Text] [PDF]

Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist

M Otsuka, H Takahashi, M Shiratori, H Chiba, and S Abe
Thorax 2004 59: 31-38. [Abstract] [Full Text] [PDF]

Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome

P M Turkington, M Sircar, D Saralaya, and M W Elliott
Thorax 2004 59: 56-59. [Abstract] [Full Text] [PDF]

Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis

C Dezateux, S Lum, A-F Hoo, J Hawdon, K Costeloe, and J Stocks
Thorax 2004 59: 60-66. [Abstract] [Full Text] [PDF]

Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City

I Romieu, J J Sienra-Monge, M Ramírez-Aguilar, H Moreno-Macías, N I Reyes-Ruiz, B Estela del Río-Navarro, M Hernández-Avila, and S J London
Thorax 2004 59: 8-10. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Leigh, R., Pizzichini, M. M. M., Morris, M. M., Maltais, F., Hargreave, F. E., Pizzichini, E. (2006). Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 27: 964-971 [Abstract] [Full Text]  
• Scott, S, Walker, P, Calverley, P M A (2006). COPD exacerbations {middle dot} 4: Prevention. Thorax 61: 440-447 [Abstract] [Full Text]  
• Laude, E. A., Duffy, N. C., Baveystock, C., Dougill, B., Campbell, M. J., Lawson, R., Jones, P. W., Calverley, P. M. (2006). The Effect of Helium and Oxygen on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial. Am. J. Respir. Crit. Care Med. 173: 865-870 [Abstract] [Full Text]  
• Saha, S., Siva, R., Brightling, C. E., Pavord, I. D. (2006). COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.. Eur Respir J 27: 863-865 [Full Text]  
• Lindberg, A., Eriksson, B., Larsson, L.-G., Ronmark, E., Sandstrom, T., Lundback, B. (2006). Seven-Year Cumulative Incidence of COPD in an Age-Stratified General Population Sample.. Chest 129: 879-885 [Abstract] [Full Text]  
• Cox, M, Kemp, R, Anwar, S, Athey, V, Aung, T, Moloney, E D (2006). Non-invasive monitoring of CO2 levels in patients using NIV for AECOPD.. Thorax 61: 363-364 [Full Text]  
• Baker, E H, Janaway, C H, Philips, B J, Brennan, A L, Baines, D L, Wood, D M, Jones, P W (2006). Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 61: 284-289 [Abstract] [Full Text]  
• Shelton, R J, Rigby, A S, Cleland, J G F, Clark, A L (2006). Effect of a community heart failure clinic on uptake of {beta} blockers by patients with obstructive airways disease and heart failure. Heart 92: 331-336 [Abstract] [Full Text]  
• Imperatori, A, Harrison, R N, Leitch, D N, Rovera, F, Lepore, G, Dionigi, G, Sutton, P, Dominioni, L (2006). Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival. Thorax 61: 232-239 [Abstract] [Full Text]  
• Connolly, M. J. (2006). Non-invasive ventilation in elderly patients with acute exacerbations of COPD: bringing pressure to bear. Age Ageing 35: 1-2 [Full Text]  
• Balami, J. S., Packham, S. M., Gosney, M. A. (2006). Non-invasive ventilation for respiratory failure due to acute exacerbations of chronic obstructive pulmonary disease in older patients. Age Ageing 35: 75-79 [Full Text]  
• Booker, R. (2005). Effective communication with the patient. ERR 14: 93-96 [Abstract] [Full Text]  
• Aliverti, A, Rodger, K, Dellaca, R L, Stevenson, N, Lo Mauro, A, Pedotti, A, Calverley, P M A (2005). Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD. Thorax 60: 916-924 [Abstract] [Full Text]  
• Lacasse, Y., Maltais, F. (2005). From the authors. Eur Respir J 26: 748-748 [Full Text]  
• Verleden, G. M., Decramer, M., Gosselink, R., Demedts, M. (2005). INTRODUCTION. ERR 14: 1-1 [Full Text]  
• Sewell, L., Singh, S. J., Williams, J. E.A., Collier, R., Morgan, M. D.L. (2005). Can Individualized Rehabilitation Improve Functional Independence in Elderly Patients With COPD?. Chest 128: 1194-1200 [Abstract] [Full Text]  
• Town, G I (2005). Aminophylline for COPD exacerbations? Not usually. Thorax 60: 709-709 [Full Text]  
• Duffy, N, Walker, P, Diamantea, F, Calverley, P M A, Davies, L (2005). Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Thorax 60: 713-717 [Abstract] [Full Text]  
• Anthonisen, N. R., Lindgren, P. G., Tashkin, D. P., Kanner, R. E., Scanlon, P. D., Connett, J. E., for the Lung Health Study Research Group, (2005). Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 26: 45-51 [Abstract] [Full Text]  
• Lacasse, Y., Lecours, R., Pelletier, C., Begin, R., Maltais, F. (2005). Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 25: 1032-1038 [Abstract] [Full Text]  
• Meldrum, M, Rawbone, R, Curran, A D, Fishwick, D (2005). The role of occupation in the development of chronic obstructive pulmonary disease (COPD). Occup. Environ. Med. 62: 212-214 [Full Text]  
• Corner, J, Hopkinson, J, Fitzsimmons, D, Barclay, S, Muers, M (2005). Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis. Thorax 60: 314-319 [Abstract] [Full Text]  
• Borrill, Z., Starkey, C., Vestbo, J., Singh, D. (2005). Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J 25: 269-274 [Abstract] [Full Text]  
• Bolton, C. E., Ionescu, A. A., Shiels, K. M., Pettit, R. J., Edwards, P. H., Stone, M. D., Nixon, L. S., Evans, W. D., Griffiths, T. L., Shale, D. J. (2004). Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 170: 1286-1293 [Abstract] [Full Text]  
• Wedzicha, J A, Johnston, S L, Mitchell, D M (2004). Thorax annual report: 1 October 2003 to 30 September 2004. Thorax 59: 1012-1015 [Full Text]  
• MacNee, W. (2004). Guidelines for chronic obstructive pulmonary disease. BMJ 329: 361-363 [Full Text]  
• Kostopoulou, O, Wildman, M (2004). Sources of variability in uncertain medical decisions in the ICU: a process tracing study. Qual Saf Health Care 13: 272-280 [Abstract] [Full Text]  
• Roberts, C M (2004). Short burst oxygen therapy for relief of breathlessness in COPD. Thorax 59: 638-640 [Full Text]